The lived reality of Type 1 diabetes: management technology, mental health, quality of life, and family support, grounded in current research.
Newest public articles in this topic cluster.
Highest growth-index pieces and decision-engine promote picks — still evidence-labeled, not medical advice.
New living with t1d research relevant to Type 1 diabetes, summarized with its evidence label.
Insulin pumps automate insulin delivery 24/7 through a small device worn on your body. Understanding how they work can help you decide if this technology might fit your life with Type 1 diabetes.
Scientists are exploring smaller, more flexible antibody fragments called scFv as potential treatments for Type 1 diabetes. These engineered molecules could target the immune system and metabolic problems that drive the disease.
A team at the University of Colorado Boulder is developing algorithms that could help bionic pancreas devices anticipate blood sugar changes rather than simply respond to them. The goal: give people with Type 1 diabetes more freedom and less constant monitoring.
Misdiagnosis of Type 1 diabetes as Type 2 can delay proper care and treatment. Understanding how these conditions differ may help catch Type 1 earlier.
A new study shows that personalized digital support—delivered through text messages and targeted information—may help emerging adults navigate the complex shift from pediatric to adult diabetes care. Researchers identified which types of support matter most to different people.
Scientists are working to develop insulin you can swallow instead of inject. Recent trials show progress, but real-world use remains on the horizon.
A new study suggests that how you feel day-to-day may align better with your own typical glucose patterns than with standard medical targets. Here's what the research shows about the gap between guidelines and lived experience.
Running out of insulin before your insulin pump is due for a scheduled change can be stressful. Here's what you need to know about staying prepared and managing this common situation.
Beta Bionics has unveiled early designs for Mint, a tubeless insulin pump currently in development. Here's what the company has shared so far about its features and design.
A new study finds that getting started on a tubeless insulin pump takes about 13 minutes less than a traditional tubed pump. Nurses say both options work equally well, but the faster setup could reduce barriers to getting on pump therapy.
Insulin pumps deliver medication continuously under the skin using a small computerized device. Here's what you need to know about how they work and how they're managed.
New research reviews how automated insulin delivery systems perform during pregnancy in people with Type 1 diabetes, highlighting which systems are available and what expectations are realistic.
New research suggests that the way people think about their own thinking—called metacognitive beliefs—may play a specific role in diabetes-related emotional distress. Understanding this connection could open new paths for psychological support.
Insulin pumps like the OmniPod have expiration dates, and using an expired device can affect your blood sugar management. Here's what you need to know about replacing your pump.
A new study finds that adolescents who develop stronger skills in using online health information and tools tend to practice better diabetes self-care—and that improved self-care is linked to better quality of life.
Researchers analyzed decades of studies comparing newer fast-acting insulins to older human insulin. Here's what the evidence shows for people using multiple daily injections.
A large study of veterans found that continuous glucose monitoring was associated with reduced death rates over several years. The benefit was strongest in older patients and those not using insulin pumps.
Continuous glucose monitors generate far more data than older blood tests. Researchers and clinicians are developing new ways to interpret that data—and working to ensure everyone speaks the same language.
Researchers are launching a pilot study to explore whether pregnant people with type 1 diabetes can safely continue using their insulin pumps during labor, rather than switching to IV insulin as is currently standard practice.
A new review of published research suggests that people with Type 1 diabetes may be able to keep using their automated insulin delivery systems during hospitalization, but more evidence is still needed.
New studies compare different approaches to automated insulin delivery and find consistent improvements in blood sugar control—especially for young people switching from manual injections.
A new study examined how common overweight and obesity are among adults with type 1 diabetes, and what factors—from insulin doses to emotional health—may play a role.
Switching to an automated insulin pump requires patience as the system learns your insulin needs. Early experiences can feel unpredictable, but understanding what's happening can help you manage the adjustment period.
A longtime Omnipod user tried a traditional tubed pump for the first time and reflected on what stood out. Here's what the comparison revealed about daily life with each pump type.
A real-world study of a flexible insulin pump system found that most adults using it achieved good blood sugar control and reported improvements in quality of life. However, low blood sugar events remained a concern for some users.
A new study shows that insulin sensitivity changes throughout the menstrual cycle in people with Type 1 diabetes using automated insulin delivery systems. Understanding these patterns may help with blood sugar management.
A new study suggests that children's ability to plan, organize, and manage tasks—called executive function—may play an important role in how they and their families experience daily life with Type 1 diabetes.
A new study reveals an unexpected connection: teens whose caregivers have very low anxiety levels tend to have higher blood sugar levels. Researchers say this points to how caregiver involvement—not just stress—shapes diabetes management.
A new study finds that tirzepatide, a medication originally developed for type 2 diabetes and weight management, was associated with significant weight loss and reduced insulin needs in people with type 1 diabetes who are overweight or obese. The findings suggest potential benefits, though more research is needed.
A Type 1 diabetic shares her troubleshooting process after experiencing repeated pod failures and discovers an unexpected culprit. Her experience may help others facing similar issues.
Insulin pump management involves practical details—organizing supplies, checking blood sugar, loading cartridges, and finding the right infusion site. Here's what one person's real routine looks like.
A new study of young people with Type 1 diabetes found that those with an evening chronotype—a natural preference for staying up late—had higher blood sugar levels and reported lower quality of life than morning-oriented peers.
A new study of pregnant women with Type 1 diabetes suggests that time in range may be a better predictor of complications than HbA1c alone—and shows that even with good control, larger babies remain common.
A year-long study of adults using Medtronic's 670G hybrid closed-loop insulin pump showed improvements in blood sugar control and quality of life—but the system worked best when users trusted it to work automatically.
A large real-world study shows how adjusting your low-glucose alert settings on automated insulin pumps can help you stay in range while keeping hypoglycemia rare. Here's what the data reveals about choosing the right threshold for your needs.
Recent approvals and clinical evidence show automated insulin delivery systems are expanding beyond standard Type 1 diabetes care into pregnancy management and emerging Type 2 diabetes treatment. Here's what the latest research tells us.
A new study shows that the type of insulin delivery system families use—from pens to automated pumps—affects not only blood sugar control but also how much stress parents experience managing their child's diabetes.
New real-world data from nearly 70,000 users reveals how the Omnipod 5 automated insulin delivery system performs in everyday life, and what glucose targets work best.
Real-world studies demonstrate that automated insulin delivery systems help young people with Type 1 diabetes spend more time in their target glucose range. Researchers are tracking how these devices perform outside clinical trials.
A new study shows that children and adolescents who switch from daily insulin injections to pump therapy—especially automated systems—see meaningful improvements in their glucose control within the first six months.
A case study shows how one person with Type 1 diabetes and insulin resistance improved their blood sugar control by switching insulin formulations while using an automated insulin delivery system.
A study of 138 children in Khartoum reveals how age, diabetes control, and family dynamics shape daily life with Type 1 diabetes—and where children and parents see things differently.
A large study called MeDiPA is investigating whether diet and exercise changes can help people on blood pressure medication achieve their treatment goals. The research focuses on patients whose blood pressure remains high despite taking medication.
A new study shows that a structured insulin protocol can help keep blood sugar stable for women with Type 1 diabetes during induced labor and delivery. Here's what the research found.
Researchers in British Columbia are running a trial of REACHOUT, a mobile app that connects adults with type 1 diabetes to trained peer supporters. The study aims to learn whether this kind of digital peer support can reduce the emotional burden of managing T1D.
Omnipod 5 is an automated insulin delivery system that adjusts your insulin dose based on real-time glucose readings. Here's how it works and what makes it different.
A new study shows that spiritual support addresses real emotional struggles many young people and caregivers face with diabetes—and that trained chaplains may be an underutilized resource in diabetes care.
A large study tracked how youth with Type 1 diabetes fared after switching to automated insulin delivery systems. Researchers found that while everyone improved quickly at first, long-term results varied significantly based on how people used the technology and other factors.
A study measuring insulin pump data from young adults aged 18-22 found that taking insulin at mealtimes is linked to better blood sugar control. The research also uncovered a concerning trend: emerging adults are bolusing at meals less often than teenagers do.
Some people are initially diagnosed with Type 2 diabetes when they actually have Type 1. Understanding the differences can help you get the right diagnosis and care plan.
The Omnipod 5, Tandem t:slim X2, and Medtronic 780G each rely on different continuous glucose monitors. Here's what those differences mean for users.
A new study reveals that people with Type 1 diabetes in underserved areas face significant emotional burdens alongside their disease management. Understanding these challenges is the first step toward better support.
A new 8-week study of the twiist AID system in 19 adults with Type 1 diabetes found that participants spent about 70% of their time in target glucose ranges. The system detected potential insulin delivery problems quickly, helping users stay on track with their insulin therapy.
A new case report shows that automated insulin delivery systems can work for people with type 1 diabetes facing additional health challenges, including kidney disease requiring dialysis. Experts say more research is needed to confirm safety and effectiveness in these complex situations.
A large French study tracked adults using two popular automated insulin delivery systems and found that how well someone's blood sugar was controlled before starting the system was the strongest predictor of meeting targets a year later.
A new study reveals that for lower-income youth and youth of color with Type 1 diabetes, having access to insulin pumps and CGM devices is only part of the challenge. Social barriers at school and limited connections to other Type 1 families can make it harder to actually use these tools.
A new study using continuous glucose monitoring data found that insulin analogues helped young people spend a bit more time in their target blood sugar range and experience fewer low blood sugar episodes compared to human insulin.
Researchers at the University of Colorado Boulder are working to improve how artificial pancreas devices manage Type 1 diabetes by adding predictive algorithms that look beyond just current blood sugar numbers.
The FDA-approved bionic pancreas uses artificial intelligence to automate insulin dosing with just one simple meal entry per day. For teens like gymnast Mia Campos, it means less time managing diabetes and more time doing what she loves.
Closed-loop insulin pumps like the Omnipod 5 can adjust insulin delivery in real time based on continuous glucose monitor data. We break down how this automation actually works in daily life.
A first-time user walks through unboxing the Omnipod 5 tubeless insulin pump system and preparing for that first pod application. Here's what you need to know before you start.
Omnipod 5 is an automated insulin delivery system that works with your Dexcom G6 continuous glucose monitor to help manage blood sugar. Here's what you need to know about how it works and what to expect.
A new study gathered feedback from teenagers and young adults who tested an app designed to support emotional well-being alongside diabetes management. Here's what they said worked—and what could improve.
A real-world study of the A8 TouchCare Nano system found that children and adolescents achieved better blood sugar control within weeks of starting the device. Researchers saw improvements in key measures and no serious safety concerns over six months.
A major review of research shows that emotional stress related to managing type 1 diabetes is common and linked to real health outcomes. Understanding diabetes distress matters for your whole-person care.
A new study compared how two popular automated insulin delivery systems handled unannounced meals in teenagers with Type 1 diabetes. Both systems kept blood sugar stable, but one showed a slight edge when meals came without warning.
New research supports continuing automated insulin delivery systems throughout pregnancy and delivery for women with type 1 diabetes, rather than switching to older insulin delivery methods. The key is careful planning and meeting specific safety criteria with your healthcare team.
A new government-funded clinic system in West Bengal shows that accessible, structured diabetes care can significantly improve blood sugar control and reduce costs for families, even in resource-limited settings.
A new study following families using the CamAPS FX hybrid closed-loop system found that while blood sugar improvements appear quickly, parents' trust and positive feelings about the technology build gradually—especially after living with it at home for over a year.
A clinical trial found that a psychoeducation program called HARPdoc helped address the cognitive and emotional barriers that make it harder for some adults to recognize and avoid dangerously low blood sugar episodes.
One person shares their initial experience transitioning from the Dexcom G6 to the newer G7 continuous glucose monitor. Here's what stood out in those first moments.
Researchers are launching a clinical trial to see whether a specialized cognitive dissonance-based group intervention can reduce eating disorder risk in young women with Type 1 diabetes. The program will be delivered virtually over six weeks.
A new study shows that starting automated insulin delivery shortly after beginning insulin pump therapy can significantly improve blood sugar control. The improvement came without serious safety concerns, though quality of life measures didn't change.
A Type 1 diabetes community member shares her experience with being initially misdiagnosed and the challenges she faced along the way.
Researchers have validated a questionnaire designed to help healthcare providers understand how type 1 diabetes affects the emotional, social, and physical well-being of young people. The tool is now available in Swedish.
The Omnipod 5 insulin pump received FDA approval in 2022, offering a tubeless option that works with continuous glucose monitoring. Here's what the approval means for people with Type 1 diabetes.
Youth with type 1 diabetes face higher rates of depression, anxiety, and other mental health conditions that can make diabetes management harder. New research shows that integrating mental health support into diabetes care improves outcomes.
Researchers are developing short, self-guided digital programs to help teens with Type 1 diabetes manage depression and other mental health challenges. These tools could fill gaps in mental health care, especially for families with limited access to traditional therapy.
Latent autoimmune diabetes in adults (LADA) is frequently misdiagnosed as Type 2 diabetes because its slower onset in middle-aged and older adults looks different from Type 1 diabetes in children. Understanding the differences can help you get the right diagnosis sooner.
The FDA-cleared tubeless pump system showed meaningful improvements in time-in-range and A1C levels in clinical trials. Here's what the evidence actually demonstrated.
A new psychological intervention designed specifically for young adults with Type 1 diabetes shows promise in reducing the emotional burden of disease management. The approach combines peer support with evidence-based coping strategies.
A new study found that people with a specific genetic mitochondrial disease show distinct changes in their gut bacteria compared to healthy individuals and those with Type 1 diabetes. Understanding these differences could eventually inform better approaches to managing gastrointestinal symptoms.
A real-world study of 100 people with Type 1 diabetes shows that the Omnipod 5 closed-loop system improved blood sugar levels and held steady over 12 months. Researchers also found hints about how starting blood sugar levels may affect eye disease risk.
A large study of children and teens using the MiniMed 780G automated insulin delivery system found that blood sugar control remained stable over three years, though the way the device was used shifted over time.
A new study from Turkey shows that government reimbursement for continuous glucose monitors dramatically increased their use among young people with Type 1 diabetes. But the impact on blood sugar control was more modest than expected.
A case study shows how an automated insulin pump system, combined with education and mental health support, improved both blood sugar control and emotional well-being in a patient with long-standing diabetes and serious complications.
A new study shows that when young people with Type 1 diabetes experience low blood sugar while using automated insulin delivery systems, they often swing to high blood sugar afterward. Researchers found ways this pattern affects overall glucose control.
A major new analysis reveals that vision loss from diabetes complications is increasing worldwide among working-age adults, with projections showing the trend will continue through 2050.
A major study from Belgium tracking people with Type 1 diabetes over 14 years shows steady improvements in blood sugar management, especially among those using newer insulin and glucose monitoring systems.
A new study tracking children and adolescents in Taiwan shows that advances in insulin, glucose monitoring, and access to testing supplies have helped more young people achieve better blood sugar management since 2000.
A healthcare provider with Type 1 diabetes shares practical insights from her experience with the Omnipod 5 automated insulin delivery system, including what the algorithm handles well and where manual management still matters.
A long-time Type 1 user shares her experience switching to the Omnipod 5 insulin pump, including the technical challenges she faced and how working with support helped her find solutions.
A new review of 23 studies found that gamified apps and websites can help children with Type 1 diabetes improve their self-management and blood sugar control. But experts say more work is needed to understand which approaches work best and last the longest.
A new study found that adults with Type 1 diabetes achieved similar blood sugar control whether they learned to use an advanced insulin pump through virtual or in-person training. Both groups also saw significant reductions in dangerous low blood sugar events.
A major study tracking over 2,200 people with Type 1 diabetes found that automated insulin delivery systems sustained their benefits over two years, with most users staying on the technology and showing improved blood sugar control.
After 20 years with Type 1 diabetes, one person shares what it's like to transition from continuous glucose monitoring alone to adding an insulin pump. Here's what the first three months looked like.
The integration between Dexcom's smallest sensor yet and the tubeless Omnipod 5 pump is now official, allowing continuous glucose data to flow directly to your insulin pump every 5 minutes.
A long-time insulin pump user shares her honest perspective on switching to the OmniPod 5, including what she sees as real benefits and tradeoffs in daily diabetes management.
The Omnipod 5 is a tubeless insulin pump option that appeals to people who want freedom from tubing or feel anxious about traditional pump therapy. Understanding how it works and whether it fits your management style is key to making the right choice.
A major review of CGM studies reveals consistent improvements in blood sugar levels and fewer low blood sugar events for people with Type 1 diabetes. Here's what you need to know about how this technology is changing diabetes management.
A real-world study shows that eliminating prior authorization for insulin pumps and continuous glucose monitors led to faster access and better blood sugar control for people with Type 1 diabetes in an underserved clinic.